feed,title,long_url,short_url
SeekingAlpha,Sarepta Phase 3 study for DMD drug fails to meet primary endpoint,https://seekingalpha.com/news/4026637,
SeekingAlpha,Hubbell to buy Systems Control in $1.1B deal,https://seekingalpha.com/news/4026636,
SeekingAlpha,"BrightSpire Capital Non-GAAP EPS of $0.28 beats by $0.07, revenue of $59.09M",https://seekingalpha.com/news/4026635,
SeekingAlpha,"SolarWinds, chief information security officer charged with fraud by SEC",https://seekingalpha.com/news/4026633,
